MYOCURE across the pond

The MYOCURE consortium was almost entirely represented at this year’s American Society of Gene & Cell Therapy (ASGCT) annual meeting, which took place in Washington DC from May 10th -13th, 2017.

Each year more than 2.000 international participants including scientists, physicians, patient advocates, and other professionals come together to present their work and discuss the latest advances in the field of gene and cell therapy.

The MYOCURE partners used this important meeting for a work- group-meeting, where they jointly discussed the next steps within the project towards the ultimate goal of developing a novel, clinically-translatable one-treatment gene therapy platform for patients suffering from MTM and GSD II.